Zobrazeno 1 - 10
of 202
pro vyhledávání: '"Kalirai S"'
Autor:
Bhutani T; Psoriasis and Skin Treatment Center, University of California San Francisco, San Francisco, CA, USA., Jayade S; OPEN Health Evidence & Access, Hingham, MA, USA., Rege S; OPEN Health Evidence & Access, Hingham, MA, USA., Penton H; OPEN Health Evidence & Access, Rotterdam, The Netherlands., Patel V; Research and Development, Bristol Myers Squibb, Princeton, NJ, USA., Kalirai S; Research and Development, Bristol Myers Squibb, Princeton, NJ, USA., Wolin D; RTI Health Solutions, Research Triangle Park, NC, USA., Boyle K; RTI Health Solutions, Research Triangle Park, NC, USA., Seigel L; Research and Development, Bristol Myers Squibb, Princeton, NJ, USA.
Publikováno v:
The Journal of dermatological treatment [J Dermatolog Treat] 2024 Dec; Vol. 35 (1), pp. 2366532. Date of Electronic Publication: 2024 Jun 24.
Autor:
Kalirai S, Ivanova JI, Perez-Nieves M, Stephenson JJ, Hadjiyianni I, Grabner M, Pollom RD, Geremakis C, Reed BL, Fisher L
Publikováno v:
Diabetes, Metabolic Syndrome and Obesity, Vol Volume 13, Pp 1023-1033 (2020)
Samaneh Kalirai,1 Jasmina I Ivanova,2 Magaly Perez-Nieves,1 Judith J Stephenson,3 Irene Hadjiyianni,1 Michael Grabner,3 Roy Daniel Pollom,1 Caroline Geremakis,3 Beverly L Reed,1 Lawrence Fisher4 1Eli Lilly and Company, Indianapolis, IN, USA; 2Analysi
Externí odkaz:
https://doaj.org/article/ee0bcfb9873f45e1941eba8d2c0c710c
Publikováno v:
In Chemical Physics 5 November 2015 461:117-124
Autor:
Armstrong AW; Division of Dermatology, David Geffen Department of Medicine, University of California Los Angeles, 200 Medical Plaza, Suite 450, Los Angeles, CA, 90095, USA. armstrongpublication@gmail.com., Jayade S; OPEN Health Evidence & Access, Bethesda, MD, USA., Rege S; OPEN Health Evidence & Access, Bethesda, MD, USA., Joshi N; OPEN Health Evidence & Access, Bethesda, MD, USA., Patel V; Bristol Myers Squibb, Princeton, NJ, USA., Kalirai S; Bristol Myers Squibb, Princeton, NJ, USA., Wolin D; RTI Health Solutions, Research Triangle Park, NC, USA., Boyle K; RTI Health Solutions, Research Triangle Park, NC, USA., Patel D; OPEN Health Evidence & Access, Bethesda, MD, USA., Seigel L; Bristol Myers Squibb, Princeton, NJ, USA.
Publikováno v:
Dermatology and therapy [Dermatol Ther (Heidelb)] 2024 Feb; Vol. 14 (2), pp. 421-439. Date of Electronic Publication: 2024 Jan 22.
Autor:
Wu JJ; Department of Dermatology, University of Miami Miller School of Medicine, Miami, FL, USA., Wang CA; Real-World Analytics & Data Science (RADS), CORDS-CIF for Cardiovascular, Immunology and Fibrosis, Bristol Myers Squibb, Princeton, NJ, USA., Jobson G; Offshore Delivery, Mu Sigma, Bangalore, India., Davidson D; Immunology and Fibrosis, Bristol Myers Squibb, Princeton, NJ, USA., Kalirai S; Worldwide HEOR - US Market, Immunology, Bristol Myers Squibb, Princeton, NJ, USA., Zhu J; Real-World Analytics & Data Science (RADS), CORDS-CIF for Cardiovascular, Immunology and Fibrosis, Bristol Myers Squibb, Princeton, NJ, USA., Suryavanshi M; HEOR Markets Department, Bristol Myers Squibb, Princeton, NJ, USA., Mittal M; Offshore Delivery, Mu Sigma, Bangalore, India., Patel V; Worldwide HEOR - US Market, Immunology, Bristol Myers Squibb, Princeton, NJ, USA., Seigel L; Worldwide HEOR - US Market, Immunology, Bristol Myers Squibb, Princeton, NJ, USA.
Publikováno v:
The Journal of dermatological treatment [J Dermatolog Treat] 2023 Dec; Vol. 34 (1), pp. 2177095.
Autor:
Schmidt L; Springfield Clinic, Effingham, IL, USA., Wang CA; Bristol Myers Squibb, Princeton, NJ, USA., Patel V; Bristol Myers Squibb, Princeton, NJ, USA. Vardhaman.patel@bms.com.; Bristol Myers Squibb, 3410 Princeton Pike, Princeton, NJ, 08648, USA. Vardhaman.patel@bms.com., Davidson D; Bristol Myers Squibb, Princeton, NJ, USA., Kalirai S; Bristol Myers Squibb, Princeton, NJ, USA., Panda A; Mu Sigma, Bengaluru, Karnataka, India., Seigel L; Bristol Myers Squibb, Princeton, NJ, USA.
Publikováno v:
Dermatology and therapy [Dermatol Ther (Heidelb)] 2023 Sep; Vol. 13 (9), pp. 2019-2030. Date of Electronic Publication: 2023 Jul 30.
Publikováno v:
In Value in Health June 2023 26(6) Supplement:S140-S141
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Fluid Catalytic Cracking (FCC) catalyst particles are complex, hierarchical, multi-component systems that are used ubiquitously for the production of valuable hydrocarbons such as gasoline and propylene from crude oil feedstocks. In the FCC unit, hig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::f73571c2019ae48d321febba97f695f5
https://dspace.library.uu.nl/handle/1874/341584
https://dspace.library.uu.nl/handle/1874/341584
Autor:
Pinter, Andreas1 (AUTHOR) andreas.pinter@kgu.de, Soliman, Ahmed M.2 (AUTHOR), Manz, Karina C.3 (AUTHOR), Weber, Valeria3 (AUTHOR), Ludwig, Paul4 (AUTHOR), Mocek, Anja3 (AUTHOR), Höer, Ariane3 (AUTHOR), Lebwohl, Mark G.5 (AUTHOR)
Publikováno v:
JEADV Clinical Practice. Dec2024, Vol. 3 Issue 5, p1537-1547. 11p.